Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagai, R.
Right arrow Articles by Horiuchi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagai, R.
Right arrow Articles by Horiuchi, S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 10 1714-1723, Copyright © 2000 by American Diabetes Association


ARTICLES

Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor

R Nagai, K Matsumoto, X Ling, H Suzuki, T Araki and S Horiuchi
Department of Biochemistry, Kumamoto University School of Medicine, Japan.

Long-term incubation of proteins with glucose leads to the formation of advanced glycation end products (AGEs) that are recognized by AGE receptors. Glyoxal, glycolaldehyde (GA), and methylglyoxal are potential intermediates for the formation of AGE structures such as Nomega-(carboxymethyl)lysine (CML). We evaluated the contribution of these aldehydes to the formation of AGE structure(s), particularly the structure important for the receptor-mediated endocytic uptake of AGE proteins by macrophages. GA-modified bovine serum albumin (BSA), methylglyoxal-modified BSA (MG-BSA), and glyoxal-modified BSA (GO-BSA) were prepared, and their physicochemical, immunological, and biologic properties were compared with those of glucose-derived AGE-BSA. CML contents were high in GO-BSA and low in GA-modified BSA (GA-BSA) but did not exist in MG-BSA. The fluorescence patterns of GA-BSA and MG-BSA were similar to those of glucose-derived AGE-BSA but were weak in GO-BSA. Immunochemically, the antibody against non-CML structures of glucose-derived AGE-BSA reacted strongly with GA-BSA and weakly with GO-BSA but did not react with MG-BSA. The negative charge of these ligands increased to a similar extent. However, GA-BSA, but not MG-BSA or GO-BSA, underwent receptor-mediated endocytosis by the macrophage-derived cell line RAW 264.7, which was effectively inhibited by glucose-derived AGE-BSA, acetylated LDL, and oxidized LDL, which are well-known ligands for the macrophage type I and type II class A scavenger receptors (MSR-A). The endocytic uptake of GA-BSA by mouse peritoneal macrophages was also significant, but that by peritoneal macrophages from MSR-A-deficient mice was markedly reduced. Our results suggest that GA serves as an important intermediate for the generation of AGE structure(s) responsible for recognition by MSR-A.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J BiochemHome page
N. Nakano, K. Fukuhara-Takaki, T. Jono, K. Nakajou, N. Eto, S. Horiuchi, M. Takeya, and R. Nagai
Association of Advanced Glycation End Products with A549 Cells, a Human Pulmonary Epithelial Cell Line, Is Mediated by a Receptor Distinct from the Scavenger Receptor Family and RAGE.
J. Biochem., May 1, 2006; 139(5): 821 - 829.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
K. Nakajou, S. Horiuchi, M. Sakai, K. Hirata, M. Tanaka, M. Takeya, T. Kai, and M. Otagiri
CD36 Is Not Involved in Scavenger Receptor-Mediated Endocytic Uptake of Glycolaldehyde- and Methylglyoxal-Modified Proteins by Liver Endothelial Cells
J. Biochem., May 1, 2005; 137(5): 607 - 616.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. W. Stitt, C. McGoldrick, A. Rice-McCaldin, D. R. McCance, J. V. Glenn, D. K. Hsu, F.-T. Liu, S. R. Thorpe, and T. A. Gardiner
Impaired Retinal Angiogenesis in Diabetes: Role of Advanced Glycation End Products and Galectin-3
Diabetes, March 1, 2005; 54(3): 785 - 794.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
W. Koito, T. Araki, S. Horiuchi, and R. Nagai
Conventional Antibody against N{varepsilon}-(Carboxymethyl)Lysine (CML) Shows Cross-Reaction to N{varepsilon}-(Carboxyethyl)Lysine (CEL): Immunochemical Quantification of CML with a Specific Antibody
J. Biochem., December 1, 2004; 136(6): 831 - 837.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Jozefowski and L. Kobzik
Scavenger receptor A mediates H2O2 production and suppression of IL-12 release in murine macrophages
J. Leukoc. Biol., November 1, 2004; 76(5): 1066 - 1074.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. A. Howes, Y. Liu, J. L. Dunaief, A. Milam, J. M. Frederick, A. Marks, and W. Baehr
Receptor for Advanced Glycation End Products and Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3713 - 3720.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
T. Jono, R. Nagai, X. Lin, N. Ahmed, P. J. Thornalley, M. Takeya, and S. Horiuchi
N{varepsilon}-(Carboxymethyl)lysine and 3-DG-Imidazolone Are Major AGE Structures in Protein Modification by 3-Deoxyglucosone
J. Biochem., September 1, 2004; 136(3): 351 - 358.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Slatter, N. C. Avery, and A. J. Bailey
Identification of a New Cross-link and Unique Histidine Adduct from Bovine Serum Albumin Incubated with Malondialdehyde
J. Biol. Chem., January 2, 2004; 279(1): 61 - 69.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Miele, A. Riboulet, M. A. Maitan, F. Oriente, C. Romano, P. Formisano, J. Giudicelli, F. Beguinot, and E. Van Obberghen
Human Glycated Albumin Affects Glucose Metabolism in L6 Skeletal Muscle Cells by Impairing Insulin-induced Insulin Receptor Substrate (IRS) Signaling through a Protein Kinase C{alpha}-mediated Mechanism
J. Biol. Chem., November 28, 2003; 278(48): 47376 - 47387.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. C. B. Moore, J. E. Moore, Y. Kaji, N. Frizzell, T. Usui, V. Poulaki, I. L. Campbell, A. W. Stitt, T. A. Gardiner, D. B. Archer, et al.
The Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4457 - 4464.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Nagai, C. M. Hayashi, L. Xia, M. Takeya, and S. Horiuchi
Identification in Human Atherosclerotic Lesions of GA-pyridine, a Novel Structure Derived from Glycolaldehyde-modified Proteins
J. Biol. Chem., December 6, 2002; 277(50): 48905 - 48912.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Nagai, Y. Unno, M. C. Hayashi, S. Masuda, F. Hayase, N. Kinae, and S. Horiuchi
Peroxynitrite Induces Formation of N{varepsilon}-(Carboxymethyl)Lysine by the Cleavage of Amadori Product and Generation of Glucosone and Glyoxal From Glucose: Novel Pathways for Protein Modification by Peroxynitrite
Diabetes, September 1, 2002; 51(9): 2833 - 2839.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. Zhang, S. C. Austin, and E. M. Smyth
Glycosylation of the Human Prostacyclin Receptor: Role in Ligand Binding and Signal Transduction
Mol. Pharmacol., September 1, 2001; 60(3): 480 - 487.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Ohgami, R. Nagai, M. Ikemoto, H. Arai, A. Kuniyasu, S. Horiuchi, and H. Nakayama
CD36, a Member of the Class B Scavenger Receptor Family, as a Receptor for Advanced Glycation End Products
J. Biol. Chem., January 26, 2001; 276(5): 3195 - 3202.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Chellan and R. H. Nagaraj
Early Glycation Products Produce Pentosidine Cross-links on Native Proteins. NOVEL MECHANISM OF PENTOSIDINE FORMATION AND PROPAGATION OF GLYCATION
J. Biol. Chem., February 2, 2001; 276(6): 3895 - 3903.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.